Global Health Data Exchange - Discover the World's Health Data

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

Nav

General Info
Geography 
Angola (AGO)
Armenia (ARM)
Benin (BEN)
Bhutan (BTN)
Bolivia (BOL)
Burundi (BDI)
Cambodia (KHM)
Cameroon (CMR)
Chad (TCD)
Comoros (COM)
Cuba (CUB)
Djibouti (DJI)
Eritrea (ERI)
Ethiopia (ETH)
Gambia (GMB)
Georgia (GEO)
Ghana (GHA)
Guinea (GIN)
Guyana (GUY)
Haiti (HTI)
Honduras (HND)
India (IND)
Indonesia (IDN)
Kenya (KEN)
Kiribati (KIR)
Lesotho (LSO)
Liberia (LBR)
Malawi (MWI)
Mali (MLI)
Mongolia (MNG)
Myanmar (MMR)
Nepal (NPL)
Nicaragua (NIC)
Niger (NER)
Nigeria (NGA)
Pakistan (PAK)
Rwanda (RWA)
Senegal (SEN)
Somalia (SOM)
Sri Lanka (LKA)
Sudan (SDN) (South Sudan, Sudan)
Togo (TGO)
Uganda (UGA)
Ukraine (UKR)
Viet Nam (VNM)
Yemen (YEM)
Zambia (ZMB)
Zimbabwe (ZWE)
Time period covered 
01/2005 - 12/2007
Citation
Authors 
Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY
Journal 
Vaccine
Volume 
26
Issue 
32
Pages 
4080-93
Publication year 
2008
Suggested citation 
Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine. 2008; 26(32): 4080-93.
DOI 
10.1016/j.vaccine.2008.04.053
PMID 
18550229